StockMarketWire.com - Oncology and immunology focused Tiziana Life Sciences launched a public offering of American depositary shares, to advance its R&D programmes.
The securities would be issued in the US and have a nominal value £0.03 each on the Nasdaq Global Market.
Each ADS represented five ordinary shares in Tiziana.
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.